Cargando…
Secondary Structure Changes in ApoA-I Milano (R173C) Are Not Accompanied by a Decrease in Protein Stability or Solubility
Apolipoprotein A-I (apoA-I) is the main protein of high-density lipoprotein (HDL) and a principal mediator of the reverse cholesterol transfer pathway. Variants of apoA-I have been shown to be associated with hereditary amyloidosis. We previously characterized the G26R and L178H variants that both p...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3995965/ https://www.ncbi.nlm.nih.gov/pubmed/24755625 http://dx.doi.org/10.1371/journal.pone.0096150 |
_version_ | 1782312962724200448 |
---|---|
author | Petrlova, Jitka Dalla-Riva, Jonathan Mörgelin, Matthias Lindahl, Maria Krupinska, Ewa Stenkula, Karin G. Voss, John C. Lagerstedt, Jens O. |
author_facet | Petrlova, Jitka Dalla-Riva, Jonathan Mörgelin, Matthias Lindahl, Maria Krupinska, Ewa Stenkula, Karin G. Voss, John C. Lagerstedt, Jens O. |
author_sort | Petrlova, Jitka |
collection | PubMed |
description | Apolipoprotein A-I (apoA-I) is the main protein of high-density lipoprotein (HDL) and a principal mediator of the reverse cholesterol transfer pathway. Variants of apoA-I have been shown to be associated with hereditary amyloidosis. We previously characterized the G26R and L178H variants that both possess decreased stability and increased fibril formation propensity. Here we investigate the Milano variant of apoAI (R173C; apoAI-M), which despite association with low plasma levels of HDL leads to low prevalence of cardiovascular disease in carriers of this mutation. The R173C substitution is located to a region (residues 170 to 178) that contains several fibrillogenic apoA-I variants, including the L178H variant, and therefore we investigated a potential fibrillogenic property of the apoAI-M protein. Despite the fact that apoAI-M shared several features with the L178H variant regarding increased helical content and low degree of ThT binding during prolonged incubation in physiological buffer, our electron microscopy analysis revealed no formation of fibrils. These results suggest that mutations inducing secondary structural changes may be beneficial in cases where fibril formation does not occur. |
format | Online Article Text |
id | pubmed-3995965 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-39959652014-04-25 Secondary Structure Changes in ApoA-I Milano (R173C) Are Not Accompanied by a Decrease in Protein Stability or Solubility Petrlova, Jitka Dalla-Riva, Jonathan Mörgelin, Matthias Lindahl, Maria Krupinska, Ewa Stenkula, Karin G. Voss, John C. Lagerstedt, Jens O. PLoS One Research Article Apolipoprotein A-I (apoA-I) is the main protein of high-density lipoprotein (HDL) and a principal mediator of the reverse cholesterol transfer pathway. Variants of apoA-I have been shown to be associated with hereditary amyloidosis. We previously characterized the G26R and L178H variants that both possess decreased stability and increased fibril formation propensity. Here we investigate the Milano variant of apoAI (R173C; apoAI-M), which despite association with low plasma levels of HDL leads to low prevalence of cardiovascular disease in carriers of this mutation. The R173C substitution is located to a region (residues 170 to 178) that contains several fibrillogenic apoA-I variants, including the L178H variant, and therefore we investigated a potential fibrillogenic property of the apoAI-M protein. Despite the fact that apoAI-M shared several features with the L178H variant regarding increased helical content and low degree of ThT binding during prolonged incubation in physiological buffer, our electron microscopy analysis revealed no formation of fibrils. These results suggest that mutations inducing secondary structural changes may be beneficial in cases where fibril formation does not occur. Public Library of Science 2014-04-22 /pmc/articles/PMC3995965/ /pubmed/24755625 http://dx.doi.org/10.1371/journal.pone.0096150 Text en © 2014 Petrlova et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Petrlova, Jitka Dalla-Riva, Jonathan Mörgelin, Matthias Lindahl, Maria Krupinska, Ewa Stenkula, Karin G. Voss, John C. Lagerstedt, Jens O. Secondary Structure Changes in ApoA-I Milano (R173C) Are Not Accompanied by a Decrease in Protein Stability or Solubility |
title | Secondary Structure Changes in ApoA-I Milano (R173C) Are Not Accompanied by a Decrease in Protein Stability or Solubility |
title_full | Secondary Structure Changes in ApoA-I Milano (R173C) Are Not Accompanied by a Decrease in Protein Stability or Solubility |
title_fullStr | Secondary Structure Changes in ApoA-I Milano (R173C) Are Not Accompanied by a Decrease in Protein Stability or Solubility |
title_full_unstemmed | Secondary Structure Changes in ApoA-I Milano (R173C) Are Not Accompanied by a Decrease in Protein Stability or Solubility |
title_short | Secondary Structure Changes in ApoA-I Milano (R173C) Are Not Accompanied by a Decrease in Protein Stability or Solubility |
title_sort | secondary structure changes in apoa-i milano (r173c) are not accompanied by a decrease in protein stability or solubility |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3995965/ https://www.ncbi.nlm.nih.gov/pubmed/24755625 http://dx.doi.org/10.1371/journal.pone.0096150 |
work_keys_str_mv | AT petrlovajitka secondarystructurechangesinapoaimilanor173carenotaccompaniedbyadecreaseinproteinstabilityorsolubility AT dallarivajonathan secondarystructurechangesinapoaimilanor173carenotaccompaniedbyadecreaseinproteinstabilityorsolubility AT morgelinmatthias secondarystructurechangesinapoaimilanor173carenotaccompaniedbyadecreaseinproteinstabilityorsolubility AT lindahlmaria secondarystructurechangesinapoaimilanor173carenotaccompaniedbyadecreaseinproteinstabilityorsolubility AT krupinskaewa secondarystructurechangesinapoaimilanor173carenotaccompaniedbyadecreaseinproteinstabilityorsolubility AT stenkulakaring secondarystructurechangesinapoaimilanor173carenotaccompaniedbyadecreaseinproteinstabilityorsolubility AT vossjohnc secondarystructurechangesinapoaimilanor173carenotaccompaniedbyadecreaseinproteinstabilityorsolubility AT lagerstedtjenso secondarystructurechangesinapoaimilanor173carenotaccompaniedbyadecreaseinproteinstabilityorsolubility |